Nureca Share News - Latest Updates, Live News & More

Latest news about Nureca

Nureca Limited Promoter Group Shareholding Increases to 68.09% Post Share Buyback 6 days ago

Nureca Limited's promoter group shareholding increased from 64.97% to 68.09% following completion of a share buyback program that concluded on December 24, 2025. The increase resulted from the extinguishment of 4,58,255 shares on January 07, 2026, which reduced total share capital while promoter holdings remained unchanged. The company filed the mandatory disclosure under SEBI Takeover Regulations on January 27, 2026.

Nureca Q3FY26 Results: Revenue Surges 45.7% YoY to ₹396.40 Crores, Returns to Profitability Jan 19, 2026

Nureca Limited Reports Strong Q3 FY26 Performance with 50% Revenue Growth Jan 19, 2026

Nureca Limited Completes Extinguishment of 4.58 Lakh Equity Shares Following Buyback Program Jan 10, 2026

Nureca Limited Receives Warning Letters from BSE and NSE for Non-Compliance with Committee Meeting Requirements Jan 07, 2026

More news about Nureca

10Dec 25

Nureca Limited Relocates Registered Office from Goregaon East to Andheri West

Nureca Limited has relocated its registered office from Goregaon East to Andheri West, Mumbai, effective December 10, 2025. The company has informed BSE and NSE about this development in compliance with SEBI listing regulations. The new registered office is at B-205, Dhanashree Heights, Andheri West, while maintaining its correspondence office in Chandigarh.

03Dec 25

Nureca Limited's Subsidiary Dissolved: Corporate Restructuring Move

Nureca Limited has announced the dissolution of its wholly owned subsidiary, Nureca Healthcare Private Limited, effective December 3, 2025. The dissolution was carried out under Section 248 of the Companies Act, 2013. The company has informed both BSE and NSE about this corporate action in compliance with SEBI regulations. While specific reasons for the dissolution were not disclosed, such actions typically aim to streamline operations or realign business focus.

28Nov 25

Nureca Limited Publishes Post-Buyback Public Announcement for ₹19.14 Crore Program

Nureca Limited has fulfilled regulatory compliance requirements by publishing its post-buyback public announcement across multiple newspapers following Board approval of a ₹19.14 crore share buyback program. The company appointed Mefcom Capital Markets Limited as buyback manager and designated contact persons for shareholder queries regarding the proportionate buyback process.

07Nov 25

Nureca CFO Naresh Gupta Reverses Resignation Decision

Nureca Limited's CFO, Naresh Gupta, has withdrawn his resignation submitted on October 11, 2025, citing resolution of personal issues. The company has also announced a trading window closure from November 6, 2025, until 48 hours after the board meeting on November 10, 2025, where a potential share buyback will be discussed. The trading window closure restricts designated persons from dealing in company equity shares during this period.

05Nov 25

NURECA Schedules Board Meeting to Discuss Share Buyback Proposal

Nureca Limited has announced a board meeting on November 28 to discuss a potential share buyback program. The company has informed stock exchanges about this agenda item, complying with SEBI LODR Regulations. If approved, the buyback could impact earnings per share and stock price. The final decision on buyback size, price, and method will be subject to board approval and regulatory processes.

17Oct 25

Nureca Limited Secures SEBI Nod for Share Buyback Amid Merger Process

Nureca Limited has received SEBI approval for an exemption from Regulation 24(ii) of the Buy-Back Regulations, allowing a share buyback while its merger with Nureca Technologies Private Limited is pending. The merger, approved by the board on May 20 and shareholders on June 16, is an internal restructuring with no change in shareholding pattern. Promoters will not participate in the buyback, making it exclusive to public shareholders. The company's board will consider the buyback proposal at an appropriate time, ensuring compliance with all regulations.

16Oct 25

Nureca Limited Reports Strong Q2 FY26 Performance with 21% YoY Revenue Growth

Nureca Limited, a home healthcare and wellness products company, has announced its Q2 FY2026 results. Revenue increased by 21% year-over-year to ₹37.70 crore, while net profit rose to ₹3.60 crore from a loss of ₹0.50 crore in Q2 FY2025. Operating profit surged by 237.50% to ₹3.30 crore. The company attributes its success to cost optimization, growth in quick commerce sales channels, and a digital-first approach with over 93% of revenue from online sales. Nureca maintains a debt-free, asset-light business model.

11Oct 25

Nureca Limited CFO Naresh Gupta to Step Down in January 2026

Naresh Gupta, Chief Financial Officer of Nureca Limited, has submitted his resignation. The resignation will be effective from January 9, 2026, at the close of business hours. Nureca Limited has informed the stock exchanges about this development in compliance with SEBI regulations. The company has a three-month transition period to ensure smooth handover and potentially identify a successor. This announcement comes ahead of Nureca's scheduled board meeting on October 16, 2025, to consider Q2 and half-year financial results.

24Jul 25

Nureca Limited Announces Merger with Wholly Owned Subsidiary and Strike-Off of Another

Nureca Limited approves merger with wholly owned subsidiary Nureca Technologies Private Limited, aiming to streamline operations and boost shareholder value. The merger, subject to regulatory approvals, involves Nureca Limited (Revenue: Rs 1,146.40 crores, Net Worth: Rs 1,917.38 crores) and Nureca Technologies Private Limited (Revenue: Rs 228.14 crores, Net Worth: Rs 53.94 crores). Benefits include improved efficiency, reduced overheads, and simplified group structure. Additionally, Nureca Limited approves strike-off of non-material subsidiary Nureca Healthcare Private Limited. No new shares will be issued, and shareholding pattern remains unchanged.

05May 25

Nureca Reports Strong Q4 Growth, Expands Distribution, and Outlines Strategic Priorities for FY26

Nureca Limited's Q4 FY25 revenue increased by 87% to ₹317.50 crore, with EBITDA rising 156% to ₹32.00 crore. Full-year FY25 results show 19.3% revenue growth and 1,480.6% EBITDA growth. The company partnered with Swiggy for quick commerce expansion and completed FDA registration for its manufacturing facility. Strategic priorities for FY26 include manufacturing expansion, quick commerce leadership, product innovation, and export growth.

29Apr 25

Nureca Expands Quick Commerce Reach: Dr Trust Products Now Available on Swiggy Instamart

Nureca Limited has expanded its quick commerce reach by making its flagship brand, Dr Trust, available on Swiggy Instamart. This move allows for ultra-fast doorstep delivery of essential healthcare products. Dr Trust products are now accessible across all major instant delivery platforms in India, including Blinkit and Zepto. A wide range of products, from digital weighing scales to orthopedic heat belts, are now available for instant ordering. CEO Aryan Goyal emphasized the company's focus on making healthcare frictionless and meeting urgent health needs with reliability and convenience.

21Apr 25

Nureca Secures Approval for New Manufacturing Facility in Punjab, Boosting 'Make in India' Initiative

Nureca Limited has received formal approval from the Punjab government to establish a new manufacturing facility for health and wellness equipment in Village Sundra, Zirakpur. This move aligns with the 'Make in India' initiative and falls under the Industrial and Business Development Policy (IBDP) - 2022, making Nureca eligible for various state incentives. The facility is expected to enhance domestic production capabilities, strengthen the company's market position, and contribute to local economic development.

12Apr 25

Nureca's Manufacturing Arm Secures US FDA Registration, Boosting Global Market Access

Nureca Technologies Private Limited, a subsidiary of Nureca Limited, has obtained US FDA registration for its Mohali facility. The registration (Number 3036779619) allows manufacturing and export of various medical devices to the US market. Approved products include powered heating pads, flotation therapy beds, stethoscopes, and breast pumps under brands like Dr Trust and Trumom. The facility, already CDSCO-approved and ISO-certified, manufactures a wide range of healthcare devices. This milestone is expected to significantly enhance Nureca's global market presence, particularly in the US.